Recent Articles from GlobeNewswire

Honey Badger Silver Inc., to Present at the Precious Metals & Critical Minerals Hybrid Investor Conference on May 21st
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
Aureon and Partners Deliver 100-Terabit Route for the AI Era
New multi-carrier transport network connects the Midwest to major data center hubs, reinforcing the region’s role in next-generation connectivity
By Aureon · Via GlobeNewswire · May 19, 2026
Helport AI Announces Strategic Board Appointment of Former U.S. Bank Executive Dr. Yu Pan
Company Advances Enterprise AI Governance Strategy as AI Labor Deployment Expands Across Regulated Industries
By Helport AI, Inc. · Via GlobeNewswire · May 19, 2026
Expion360 Deepens Forest River Relationship, Adding Georgetown and Dynamax Grand Sport Lines
Expanded Footprint Underscores Industry Confidence in Expion360's Certified, High-Performance Lithium Battery Technology
By Expion360 · Via GlobeNewswire · May 19, 2026
Matisse Pharmaceuticals receives FDA IND clearance for isupartob sodium
Geleen, May 19th, 2026
By Matisse Pharmaceuticals · Via GlobeNewswire · May 19, 2026
GlobalFoundries advances long-term technology innovation through investment in Playground Global
GF deepens its engagement with the startup ecosystem, partnering with experienced technology leaders to support next wave of AI data center and Physical AI technologies
By GlobalFoundries Inc. · Via GlobeNewswire · May 19, 2026
PodcastOne (Nasdaq: PODC) Renews Lindsie Chrisley’s The Southern Tea in Multiyear Deal; Podcast Exceeds 2.5 Million Downloads with 248 Episodes to Date
PodcastOne Acquires Distribution Rights to KILLR Network Show Dude Dads and It’s Library of Over 280 Episodes
By PodcastOne · Via GlobeNewswire · May 19, 2026
VPG Chief Financial Officer, William M. Clancy, Announces Retirement, Effective December 31, 2026
CHESTERBROOK, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, today announced that William M. Clancy, its Executive Vice President and Chief Financial Officer, will be retiring effective December 31, 2026, and that the Company’s Board of Directors will be conducting a search for his successor.
By Vishay Precision Group · Via GlobeNewswire · May 19, 2026
GCL Announces Expanded Strategic Investment from ADATA Technology to Accelerate Global Entertainment and Digital Growth
SINGAPORE, May 19, 2026 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd (Nasdaq: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced that its publishing subsidiary, 4Divinity Pte. Ltd. (“4Divinity”), has received an additional $10.0 million strategic investment from ADATA Technology Co., Ltd. (“ADATA”), a world leader in memory and storage solutions, following ADATA’s initial investments of $3.0 million announced in December 2025 and $10.0 million announced in January 2026. The investment provides 4Divinity with the capital to continue securing high-profile global game titles, enhancing its digital distribution infrastructure, and strengthening its position as a leading game publisher in the international market.
By GCL Global Holdings Ltd. · Via GlobeNewswire · May 19, 2026
Cemtrex’s Vicon Secures Approximately $2 Million Order for U.K. Correctional Facility Security Deployment
Significant Valerus platform order through a long-standing international integration partner
By Cemtrex Inc. · Via GlobeNewswire · May 19, 2026
Haoxi Health Technology Limited Announces 1-For-128 Reverse Share Split
BEIJING, May 19, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (NASDAQ: HAO; “we” or the “Company”), today announced that it will effect a reverse share split of its outstanding Class A ordinary shares, par value $0.0025 per share (the “Class A Ordinary Shares”) and Class B ordinary shares, par value $0.0025 per share (the “Class B Ordinary Shares”), at a ratio of 1-for-128.
SAIC Schedules First Quarter Fiscal Year 2027 Earnings Conference Call for June 1 at 10 A.M. EDT
RESTON, Va., May 19, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) is scheduled to issue its first quarter fiscal year 2027 results before market open on Monday, June 1, 2026. SAIC executive management will discuss operational and financial results in a conference call beginning at 10:00 a.m. EDT, following the issuance of the company’s earnings press release. 
By SAIC, Inc. · Via GlobeNewswire · May 19, 2026
Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
BEDFORD, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced data to be featured at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 – June 2, 2026 in Chicago, IL.
By Lantheus Holdings, Inc. · Via GlobeNewswire · May 19, 2026
Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
Acquisition gives Nexalin control of AI-integrated remote patient-monitoring, clinical data-capture and virtual-care infrastructure already deployed at UCSD
By Nexalin Technology, Inc. · Via GlobeNewswire · May 19, 2026
Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference
NEW HOPE, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that company management will be participating in the Jefferies Global Healthcare Conference.
HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network
Agreement follows Cibolo Health’s endorsement of MyoVista Insights for its network of 127 independent hospitals and reflects continued commercial momentum for HeartSciences’ ECG management platform
By HeartSciences Inc. · Via GlobeNewswire · May 19, 2026
One and One Green Technologies. INC Signs Smelting Equipment Contract to Support Electronic, Copper, and Nickel Sludge Recovery Lines with Production Targeted for Second Half of 2026
New Production Line Expected to Recover Copper, Nickel, Gold, and Silver from Industrial Hazardous Waste Streams
NodThera Announces Late-Breaking Oral Presentation at the 94th EAS Congress
BOSTON, May 19, 2026 (GLOBE NEWSWIRE) -- NodThera, the leading clinical-stage NLRP3 company developing a portfolio of potentially best-in-class brain-penetrant oral NLRP3 inhibitors to address inflammatory drivers of cardiometabolic and neurologic diseases, today announced that data from the cardiometabolic Phase 1b clinical trial of its lead candidate, ruvonoflast, previously known as NT-0796, has been accepted for a late-breaking oral presentation at the 94th European Atherosclerosis Society (EAS) Congress being held May 24-27, 2026 in Athens, Greece.
By NodThera · Via GlobeNewswire · May 19, 2026
NordStellar introduces an AI assistant to accelerate and streamline threat intelligence analysis
The new NordStellar AI assistant connects threat intelligence with AI tools, making threat exposure analysis quicker and more accessible
By NordStellar · Via GlobeNewswire · May 19, 2026
Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) -- Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug developed to address significant unmet medical needs in patients with Alzheimer's disease.
By Risen Pharma Tech Co., Ltd · Via GlobeNewswire · May 19, 2026
Toss Out the Tire Irons: New Ranger Leverless Auto Bead Lifter Takes the Strain Out of Changing Tires
Ranger tilt-back tire changer accessory improves productivity and prevents damage 
By BendPak · Via GlobeNewswire · May 19, 2026
Amplexd Therapeutics Initiates Phase 2 Clinical Trial of Investigational EGCg-Based HPV Therapy
GAITHERSBURG, Md., May 19, 2026 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd”), a U.S.-based clinical-stage biotechnology company focused on women’s health and underserved therapeutic areas, today announced authorization from the Hong Kong Department of Health to initiate a Phase 2 clinical trial evaluating its novel EGCg-based investigational therapy for precancerous cervical lesions associated with high-risk human papillomavirus (hr-HPV).
By Amplexd Therapeutics, Inc. · Via GlobeNewswire · May 19, 2026
Syntec Optics (Nasdaq: OPTX) Makes Deep Tech Deliveries for Next Gen Defense, Space, and Hyperscale AI
ROCHESTER, NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec” or the “Company”), a leading provider of products for defense tech, space tech, and other vibrant end markets, today announced a series of pioneering product delivery milestones that have taken nearly 12 months to achieve. The Company has successfully manufactured and delivered next-generation products operating at the leading edge and frontier, achieving high accuracy in nanoscale irregularity across highly complex defense, space, and Artificial Intelligence platforms. 
By Syntec Optics · Via GlobeNewswire · May 19, 2026
GDEV announces results for the first quarter of 2026
LIMASSOL, Cyprus, May 19, 2026 (GLOBE NEWSWIRE) -- GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”) released its unaudited financial and operational results for the three-month period ended March 31, 2026.
By GDEV Inc. · Via GlobeNewswire · May 19, 2026
SecureAuth Launches Agentic Authority Platform and Names Mark van Oppen Chief Revenue Officer to Lead the Next Era of Identity Security in the Age of AI
Zero-trust security for AI agents authorizes every action in real time against full request context, with industry veteran Mark van Oppen joining as CRO to drive enterprise growth
By SecureAuth Corporation · Via GlobeNewswire · May 19, 2026
Hudson InterXchange Continues 60 Hudson Expansion with Second 1MW Data Hall and Roadmap Beyond 10 MW
New High-Density Capacity Delivers Scarce Power and Contiguous Space for AI, Cloud, Financial Services and Network-Driven Workloads in New York City
By Hudson Interxchange · Via GlobeNewswire · May 19, 2026
Fluent, Inc. Selected as Commerce Media Partner for BackpackSM Media by Sallie
Partnership Powers Monetization and Advertiser Performance Across Predictive Life-Stage Intelligence
By Fluent, Inc. · Via GlobeNewswire · May 19, 2026
AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities
Increase in stockholder equity and note extension strengthen Company’s ability to advance pancreatic cancer development strategy
By AIM ImmunoTech Inc. · Via GlobeNewswire · May 19, 2026
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026
WALTHAM, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Ardelyx Inc. (Nasdaq: ARDX), (“Ardelyx” or the “Company”) a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced its participation in a fireside chat at the Jefferies Global Healthcare Conference 2026 on June 3 at 9:55 a.m. ET in New York.
By Ardelyx, Inc. · Via GlobeNewswire · May 19, 2026
Advanced Magnet Lab (AML) Awarded $2 Million Defense Logistics Agency (DLA) Contract to Qualify Innovative, 100% U.S.-Made High-Grade Sintered NdFeB Permanent Magnets for Defense
Award Advances AML's Multi-Phase Partnership with the U.S. Government and Further Establishes the Company's PM-Wire™ Manufacturing Process as a Backbone of Domestic Permanent Magnet Production
By Advanced Magnet Lab · Via GlobeNewswire · May 19, 2026
Phoenix Lighting Announces Completion of Acquisition of Rig-A-Lite
Transaction Expands Phoenix Lighting's Industrial and Commercial Lighting Portfolio and Strengthens Its Position as a Leading Manufacturer of Specification-Grade Lighting Solutions
By Phoenix Products LLC · Via GlobeNewswire · May 19, 2026
UneeQ Unveils AI Buddy at the Gartner CSO & Sales Leader Conference 2026
The first coaching capability in the market to deliver face-to-face, spoken coaching from a digital human, turning every practice session into an immediate and personal coaching conversation
By UneeQ · Via GlobeNewswire · May 19, 2026
Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1
Milestone advances commercial and manufacturing readiness ahead of anticipated pivotal study scale-up
By BONE BIOLOGICS CORPORATION · Via GlobeNewswire · May 19, 2026
Open Source Stays Open: Percona Sponsors pgBackRest to Keep PostgreSQL Backups Running
RALEIGH, N.C., May 19, 2026 (GLOBE NEWSWIRE) -- When pgBackRest's primary maintainer announced he would step away due to a lack of sustainable funding, Percona didn't wait. The open source database company today announced it has joined a group of companies to sponsor pgBackRest, one of PostgreSQL's most widely used backup and recovery tools, restoring active development and giving users a clear path forward.
By Percona · Via GlobeNewswire · May 19, 2026
Shufti Recognised as Dual Leader in Liminal's 2026 Age Verification and Age Estimation Indexes, with Exceptional Ratings Across Both Benchmarks
Liminal’s independent buyer-led research positions Shufti among the highest-scoring vendors on Product Execution, Strategy, and Market Presence, citing its risk-based age assurance, sub-second inference, and privacy-preserving on-device capabilities
By Shufti Pro Limited · Via GlobeNewswire · May 19, 2026
Stellantis MarketCenter to Launch Point Predictive’s BorrowerCheck™ with Driver’s License Scan Across U.S. Dealer Network
More than 2,600 Chrysler, Dodge, Jeep, Ram, FIAT, and Alfa Romeo dealerships will gain access to AI-powered fraud prevention and real-time identity verification directly inside the Stellantis MarketCenter platform
By Point Predictive, Inc. · Via GlobeNewswire · May 19, 2026
TON Strategy Company Highlights Launch of Acton Developer Toolchain for the TON Ecosystem
LAS VEGAS, May 19, 2026 (GLOBE NEWSWIRE) -- TON Strategy Company (“TON Strategy” or the “Company”) (Nasdaq: TONX), a digital asset treasury company dedicated to supporting the TON ecosystem, today spotlighted the recent introduction of Acton, a new integrated developer toolchain for The Open Network (“TON”). Acton is designed to simplify how developers build, test, debug, deploy and audit TON-based smart contract applications and is intended to support the next generation of AI-native and agentic applications on the TON blockchain.
By TON Strategy Company · Via GlobeNewswire · May 19, 2026
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
Veteran physician, medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience, mobility technologies, and metabolic disease
By Lifeward Ltd. · Via GlobeNewswire · May 19, 2026
Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development
Veteran biotechnology executive with more than 20 years of leadership experience spanning research, clinical development, commercialization and company building
Rocket Doctor Enters into North Star Agreement
Vancouver, BC, May 19, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that, subject to regulatory approval, it has entered into an agreement dated May 15, 2026 with North Star Investor Relations Inc. (“North Star”) pursuant to which the Company has engaged the services of North Star to provide investor relations and marketing services, beginning on May 15, 2026. 
By Rocket Doctor AI Inc. · Via GlobeNewswire · May 19, 2026
Sunrun Earns Four 2026 Buyer’s Choice Awards from ConsumerAffairs, Including Best Customer Service
The annual Buyer's Choice Awards recognize top-rated brands across key consumer categories, based on in-depth analysis of customer reviews published on ConsumerAffairs.com
By Sunrun Inc. · Via GlobeNewswire · May 19, 2026
Venture For ClimateTech Announces Cohort 6 of High-Impact Startups Advancing Climate Innovation
10 Companies Selected to Receive Up to $50,000 Each and Accelerate Commercialization of Climate Technologies
By For ClimateTech · Via GlobeNewswire · May 19, 2026
Jenfi Surpasses US$100 Million in SME Financing Across Southeast Asia
SINGAPORE, May 19, 2026 (GLOBE NEWSWIRE) -- Jenfi, a Southeast Asia-focused SME credit platform, today announced that it has surpassed US$100 million in cumulative financing originations across the region, marking a significant milestone in the company’s continued expansion across Singapore and Vietnam.
By Jenfi Pte Ltd · Via GlobeNewswire · May 19, 2026
Hudbay Publishes its 2025 Annual Report “the Gold Standard in Copper”
TORONTO, May 19, 2026 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today announced the release of its 2025 annual report (“Annual Report”), which provides updates on key business, financial and sustainability initiatives and accomplishments from last year. The sustainability disclosure in the Annual Report is aligned with recognized global reporting standards.
By Hudbay Minerals Inc. · Via GlobeNewswire · May 19, 2026
Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC
Webcast will be held Thursday, May 21, 2026, at 5:30 p.m. ET
Globavend Welcomes Pictureworks CEO to Lead Its AI-Driven Entertainment Business
PERTH, Australia, May 19, 2026 (GLOBE NEWSWIRE) -- via IBN -- Globavend Holdings Limited (NASDAQ: GVH) (“Globavend” or the “Company”), an emerging e-commerce logistics provider and digital entertainment company, today announced the appointment of Fuk Yan Tse, known as Sharon Tse (“Ms. Tse” or “Sharon”), as Chief Executive Officer of Loomi Group, the operating arm of the Company’s digital entertainment business. This newly created position follows the Company’s transformational move into the digital entertainment industry. Ms. Tse will oversee the operations and strategy of the Company’s digital entertainment business following the completion of the acquisition of Loomi Entertainment Group Limited and its subsidiaries (“Loomi Group”).
By Globavend Holdings Limited · Via GlobeNewswire · May 19, 2026
Onconetix, Inc. Announces 1-for-10 Reverse Stock Split
CINCINNATI, Ohio, May 19, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for oncology, today announced that its Board of Directors (the “Board of Directors” or “Board”) has approved a 1-for-10 reverse stock split of its outstanding shares of common stock, to be effective as of 12:01 a.m. Eastern Time on May 21, 2026.
By Onconetix, Inc. · Via GlobeNewswire · May 19, 2026
Magna Awarded Driver and Occupant Monitoring System Program With European OEM
AURORA, Ontario, May 19, 2026 (GLOBE NEWSWIRE) -- Magna has been awarded a Driver and Occupant Monitoring System (DMS/OMS) program with a European OEM. The program marks a significant expansion of Magna’s DMS/OMS across global vehicle platforms and positions the company’s mirror-integrated system as a foundational element within next-generation vehicle architecture.
By Magna International Inc. · Via GlobeNewswire · May 19, 2026
ITM to Announce Dosimetry Data from the Phase 3 COMPETE Trial at SNMMI 2026 and Host Satellite Symposium
Garching / Munich, May 19, 2026 –– ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that dosimetry data from its Phase 3 COMPETE trial will be provided in a poster presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, held from May 30 - June 2, 2026 in Los Angeles, California. ITM will also host a satellite symposium on the evolution of SSTR-targeted radiopharmaceutical therapy.Poster Presentation DetailsTitle: Accurate single-time-point dosimetry of [177Lu]Lu-edotreotide using non-linear mixed-effects modeling: results from the COMPETE Phase 3 trialDisplay Date and Location: May 31 – June 2 at the SNMMI Science PavilionSatellite Symposium DetailsTitle: ITM Dinner Symposium – The Evolution of SSTR‑Targeted Therapy – from Agonists to Antagonists and Emerging RadionuclidesObjective: Discuss the evolution of SSTR‑targeted radiopharmaceutical therapy; spanning early approaches, current ¹⁷⁷Lu agonist therapies to next‑generation ligand biology and emerging radionuclides – linking today’s clinical practice with future therapeutic directionsSpeaker: Dr. Julia Fricke, MD, Clinic for Radiology and Nuclear Medicine at the University Hospital Basel, SwitzerlandDate: May 31, 2026, 6:30 PM - 7:30 PM PTLocation: Petree Hall C, LA Convention Center, Los Angeles, CADuring the conference, ITM will exhibit its innovative isotope portfolio, including Lutetium-177, Actinium-225 and Terbium-161. Attendees will have the opportunity to learn more about the company’s innovative radiopharmaceutical pipeline and its capabilities in the manufacturing and supply of radioisotopes at booth #1523.About the COMPETE TrialThe COMPETE trial (NCT03049189) evaluated 177Lu-edotreotide (ITM-11), a proprietary, synthetic, targeted radiotherapeutic investigational agent compared to everolimus, a targeted molecular therapy, in patients with inoperable, progressive Grade 1 or Grade 2 gastroenteropancreatic neuroendocrine tumors (GEP-NETs). This trial met its primary endpoint, with 177Lu-edotreotide demonstrating clinically and statistically significant improvement in progression-free survival (PFS) compared to everolimus. 177Lu-edotreotide is an investigational product pending review by the U.S. Food and Drug Administration (FDA) and is not approved by any regulatory authority for the safety and/or efficacy of any intended use. It is also being evaluated in COMPOSE (NCT04919226), a Phase 3 study in patients with well-differentiated, aggressive Grade 2 or Grade 3, somatostatin receptor (SSTR)-positive GEP-NETs.About ITM Isotope Technologies Munich SEITM, a leading radiopharmaceutical biotech company, is dedicated to providing a new generation of radiopharmaceutical therapeutics and diagnostics for hard-to-treat tumors. We aim to meet the needs of cancer patients, clinicians and our partners through excellence in development, production and global supply of medical radioisotopes. With improved patient benefit as the driving principle for all we do, ITM advances a broad precision oncology pipeline, including multiple Phase 3 studies, combining the company’s high-quality radioisotopes with a range of targeting molecules. By leveraging our two decades of pioneering radiopharma expertise, central industry position and established global network, ITM strives to provide patients with more effective targeted treatment to improve clinical outcome and quality of life. www.itm-radiopharma.comITM ContactCorporate CommunicationsKathleen Noonan/Julia WestermeirPhone: +49 89 329 8986 1500Email: communications@itm-radiopharma.comInvestor RelationsBen OrzelekPhone: +49 89 329 8986 1009Email: investors@itm-radiopharma.com
SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
SCHAUMBURG, Ill. and DALLAS, May 19, 2026 (GLOBE NEWSWIRE) -- The Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC), a national alliance of leading academic and community based uro-oncologists, and CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced the recipients of the second annual CG-SUO-CTC NMIBC Research Fellowship designed to support the development of outstanding clinical cancer research investigators who have demonstrated a commitment to improving the understanding and treatment of Non-Muscle Invasive Bladder Cancer (NMIBC). They include:
By CG Oncology Inc. · Via GlobeNewswire · May 19, 2026
D-Orbit and ELECTRA AI Sign MoU to Bring AI Battery Intelligence to Space
~ Real-time on the satellite. Analytics across the fleet. Same brain. New frontier. ~
By ELECTRA AI · Via GlobeNewswire · May 19, 2026
Exyn Defense Subsidiary Range Advances USSOCOM Evaluation Pathway for Autonomous Systems
PHILADELPHIA, PA, May 19, 2026 (GLOBE NEWSWIRE) -- Exyn Technologies (“Exyn” or the “Company”) (NASDAQ: EXYN, EXYNW), a leader in autonomous mapping and perception-driven navigation for complex, GPS-denied environments, today announced it executed a Vendor Loan Agreement with the United States Special Operations Command (USSOCOM) to establish a pathway for future adoption of Range’s autonomy systems. Range also entered an agreement with Asylon Robotics to support the U.S. Air Force Warner Robins Air Logistics Complex, applying ExynAI to autonomous inspection and operational efficiency programs within the Organic Industrial Base (OIB).
By Exyn Technologies, Inc. · Via GlobeNewswire · May 19, 2026
LaunchDarkly Brings Runtime Control to the Agent Era
New solution gives engineering teams instantaneous control over AI agent behavior in production without redeployment
XRP POWER Launches Global App with AI-Powered Smart System, Ushering in a New Era of More Stable Returns
With the continuous development of artificial intelligence technology and the new energy industry, the digital finance sector is undergoing significant changes. Compared to past participation methods that relied on frequent trading and complex operations, more and more users are focusing on a more stable, intelligent, and efficient digital service experience. The integration of AI automation systems with the green new energy ecosystem is gradually becoming a new direction for industry development.
By XRP Power · Via GlobeNewswire · May 19, 2026
Integer Technologies and Cellula Robotics Partner to Advance Adaptive Mission Assurance for Long-Range Multi-Vehicle Undersea Operations
The collaboration will explore how Integer’s DIGIT COMMAND can layer onto Cellula’s Nexus mission control software through a back-seat driver architecture, supporting adaptive tasking, system awareness and operator confidence in communications-constrained environments
By Integer Technologies · Via GlobeNewswire · May 19, 2026
BrainHQ Awarded the Gold: Earns Trusted Digital Badge from APA Labs, a unit of American Psychological Association Services, Inc.
SAN FRANCISCO, May 19, 2026 (GLOBE NEWSWIRE) -- BrainHQ, the premier brain-training platform developed by Posit Science, has earned the Gold Badge from APA Labs – a unit of APA Services, Inc., the companion professional association of the American Psychological Association (APA). This elite status recognizes BrainHQ for excellence in clinical rigor and establishes it as a trusted, evidence-based solution in the crowded and largely unregulated digital mental health marketplace. BrainHQ is currently the third app to earn the Gold Digital Badge, and is the first app focused on brain training for cognitive enhancement.
By Posit Science · Via GlobeNewswire · May 19, 2026
TRUE-See Reports New Peer-Reviewed Publication that Highlights the Critical Role of Accuracy and Quality Standards in Medical Photography
TRUE-See’s patented technology is designed to make medical photography accurate, reliable and easily accessible
By TRUE-See Systems, Inc. · Via GlobeNewswire · May 19, 2026
Rezolve Ai Solves the 26% AI Distortion Crisis Stalling Global Retail; Peer-Reviewed Research Validates Near-Perfect Accuracy
New Research Showing 26.5% AI Product-Review Distortion and 60% Hallucination Rates Proves Commerce Needs Verified Intelligence
By Rezolve AI PLC · Via GlobeNewswire · May 19, 2026
Science 37 and Tufts CSDD Publish Landmark Study on Direct-to-Patient Clinical Trial Site Performance, Outperforming Industry Benchmarks
MORRISVILLE, N.C., May 19, 2026 (GLOBE NEWSWIRE) -- Science 37 today announced the publication of a new analysis in Applied Clinical Trials in collaboration with the Tufts Center for the Study of Drug Development (Tufts CSDD). The study evaluates the performance of Science 37’s Direct-to-Patient (DTP) Site against established industry benchmarks, providing an empirical assessment of how the DTP site model, when added along with traditional sites, can improve study performance.
By Science 37, Inc. · Via GlobeNewswire · May 19, 2026
Seven Peer-Reviewed Studies Expand Research Into Vielight’s Light-Based Neurotechnology
Toronto, Ontario, May 19, 2026 (GLOBE NEWSWIRE) --
By Vielight Inc. · Via GlobeNewswire · May 19, 2026
Arctera and Enterprise Vault Expand Leadership Team with New Sales Leaders to Drive Strategic Growth
SAN RAMON, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Arctera and Enterprise Vault, both business units of Cloud Software Group, today announced the appointment of three new sales leaders to support continued growth across its enterprise compliance and governance portfolios. The appointments include Jeff Thomas as Global Sales Leader for Enterprise Vault, along with Chris Hartley as Americas Sales Leader for Arctera and Brenda Sheahan as International Sales Leader for Arctera.
By Arctera · Via GlobeNewswire · May 19, 2026
Bitget lists Superform (UP) for Spot Trading
By Bitget Limited · Via GlobeNewswire · May 19, 2026
Mattr Reports Voting Results from Annual Meeting
TORONTO, May 19, 2026 (GLOBE NEWSWIRE) -- Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced today in accordance with Toronto Stock Exchange requirements, the voting results from its Annual Meeting held May 14, 2026 in Toronto, Ontario.
By Mattr Corp. · Via GlobeNewswire · May 19, 2026
Compass Lexecon Expands Antitrust Expertise With Addition of Two Affiliates
WASHINGTON, May 19, 2026 (GLOBE NEWSWIRE) -- Compass Lexecon, a subsidiary of FTI Consulting, Inc. (NYSE: FCN), today announced that Anja Lambrecht, a Professor of Marketing at London Business School, and Matthew Notowidigdo, the David McDaniel Keller Professor of Economics at the University of Chicago Booth School of Business, have affiliated with the firm.
By FTI Consulting, Inc. · Via GlobeNewswire · May 19, 2026
Creative Realities to Participate in Upcoming Craig-Hallum Conference
LOUISVILLE, Ky., May 19, 2026 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced that it will participate in the 23rd Annual Craig-Hallum Institutional Investor Conference in Minneapolis on Thursday, May 28, at the Depot Renaissance Hotel. The day will consist of one-on-one meetings with management, and institutional investors can contact Craig-Hallum directly to set up time with the Company.
By Creative Realities · Via GlobeNewswire · May 19, 2026
New 30-Year U.S. National Entrepreneurship Research by Ewing Marion Kauffman Foundation Indicates Rise in New Businesses Since Covid-Era Drop; Identifies Opportunities to Boost Economic Growth
Landmark research data reveals new businesses remain the engine of growth, creating more than 3 million jobs per year
Global Indemnity Group, LLC Announces Appointment of Michele Colucci to the Board of Directors
WILMINGTON, Del., May 19, 2026 (GLOBE NEWSWIRE) -- Global Indemnity Group, LLC (NASDAQ: GBLI) (“GBLI”) today announced the appointment of Michele Colucci to its Board of Directors, effective May 18, 2026.
By Global Indemnity Group, LLC · Via GlobeNewswire · May 19, 2026
RenX Advances Microtec Commercialization with Customer Sample Run in Germany
MIAMI, FL, May 19, 2026 (GLOBE NEWSWIRE) -- RenX Enterprises Corp. (NASDAQ: RENX) (“RenX” or the “Company”) today announced three operational updates supporting the planned deployment of the Microtec UTM 1200 Turbo Mill at its Myakka City, Florida facility: (1) the initiation of an customer sample run at MTDH Germany GmbH (“Microtec”); (2) the acquisition of a spare parts package bundled with the mill and (3) the funding of contract deposits to the Company’s site commissioning and electrical infrastructure partners.
By RenX Enterprises Corp. · Via GlobeNewswire · May 19, 2026
Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy
– Alterity’s novel imaging and biomarker approach positions the Company at the forefront of clinical research in MSA – 
SiTime Corporation Announces Proposed Convertible Senior Notes Offering
SANTA CLARA, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- SiTime Corporation (“SiTime”) (NASDAQ: SITM), the Precision Timing company, today announced its intent to offer, subject to market conditions and other factors, $1.1 billion aggregate principal amount of Convertible Senior Notes due in 2031 (the “Notes”) in an underwritten offering (the “Offering”). SiTime also intends to grant the underwriters of the Notes a right to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $150 million aggregate principal amount of Notes, solely to cover over-allotments, if any.
By SiTime · Via GlobeNewswire · May 19, 2026
Zenas BioPharma Announces Upcoming Presentation of Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD) at EULAR 2026 Congress
- Safety and efficacy results from the Phase 3 INDIGO trial to be presented by Emanuel Della Torre, M.D., Ph.D., on Thursday June 4, 2026, at 2:45 PM GMT -
By Zenas BioPharma · Via GlobeNewswire · May 19, 2026
CRB Horizons Report Reveals Food and Beverage Manufacturers Confront Aging Facilities, Labor Shortages, and Regulatory Pressure Amid Rising Safety Risks
Survey of 300 food and beverage leaders shows rising investment in automation and traceability, yet a persistent gap remains between strategy and execution
By CRB Group, Inc. · Via GlobeNewswire · May 19, 2026
Antalpha Reports First Quarter 2026 Results
SINGAPORE, May 19, 2026 (GLOBE NEWSWIRE) -- Antalpha Platform Holding Company (NASDAQ: ANTA) ("Antalpha" or the "Company") today announced its unaudited financial results for the first quarter ended March 31, 2026.
Vanqua Bio to Present Positive Biomarker Data from Ongoing Phase 1b Study at Upcoming Medical Conferences
CHICAGO, May 19, 2026 (GLOBE NEWSWIRE) -- Vanqua Bio, a clinical-stage biopharmaceutical company, announced that the company will present interim data from its Phase 1b study at World Parkinson’s Congress and the GBA1 Meeting 2026, both taking place in Phoenix, AZ May 22nd – May 27th.
By Vanqua Bio · Via GlobeNewswire · May 19, 2026
Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis
BOSTON, May 19, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana"), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces updated clinical data from its ongoing Expanded Access ("EA") Program evaluating intranasal foralumab in 14 patients with non-active Secondary Progressive Multiple Sclerosis (na-SPMS). The data, updated from March 2025 to as of March 2026, demonstrate that intranasal foralumab continues to be extremely well tolerated over extended treatment durations. Patients showed encouraging trends in stabilization of disability as measured by the Expanded Disability Status Scale (EDSS) and meaningful improvements in fatigue as measured by the Modified Fatigue Impact Scale (MFIS).
By Tiziana Life Sciences Ltd. · Via GlobeNewswire · May 19, 2026